Intraindividual comparison of F-18-fluorodeoxyglucose and Tc-99m-tetrofosmin in planar scintimammography and SPECT

Clinical Positron Imaging (Netherlands)

Volumn 3, Issue 1, 2000, Pages 17-29

  Ivančević, Velimir ^a   Wolter, Andreas ^a   Winzer, Klaus Jürgen ^a   Aldinger, Hans Ulrich ^a   Müller, Joachim M ^a   Munz, Dieter L ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Axillary lymph nodes; Breast cancer; FDG; Intraindividual comparison; Planar; Scintimammography; SPECT; Tetrofosmin

Indexed keywords

EID: 3042667573     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00038-2     Document Type: Article

References (55)

1. J.D.F Habbema G.V van Ootmarssen D.J van Putten Agespecific reduction in breast cancer mortality by screen analyses of the results of health insurance plans of greater New York study J. Natl. Cancer Inst. 77 1986 317 320
2. J.L Kelsey M.D Gammon The epidemiology of breast cancer Cancer 41 1991 146 165
3. R.L Wahl R.L Cody G.D Hutchins E.E Mudgett Primary and metastatic breast carcinoma initial clinical evaluation with PET with the radiolabeled glucose analogue 2(18F)-fluoro-2-deoxy-D-glucose Radiology 179 1991 765 770
4. N.Y Tse C.K Hoh R.A Hawkins The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease Ann. Surg. 216 1992 27 34
5. L.P Adler J.P Crowe N.K al Kaisi J.L Sunshine Evaluation of breast masses and axillary lymph nodes with (18F)-2-deoxy-2-fluoro-D-glucose PET Radiology 187 1993 743 750
6. R.L Wahl K Zasadny M Helvie G.D Hutchins R.L Cody Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography initial evaluation J. Clin. Oncol. 11 1993 2101 2111
7. O.E Nieweg E.E Kim W.H Wong Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Cancer 71 1993 3920 3925
8. C.K Hoh R.A Hawkins J.A Glaspy Cancer detection with whole-body PET using 2-(18F)-2-deoxy-D-glucose J. Comput. Assist. Tomogr. 17 1993 582 589
9. D.M Bruce N.T Evans S.D Heys Positron emission tomography 2-deoxy-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers Eur. J. Surg. Oncol. 21 1995 280 293
10. U Pietrzyk K Scheidhauer A Scharl A Schuster H Schicha Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging J. Nucl. Med. 36 1995 1882 1884
11. N Avril J Dose F Jänicke Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose J. Clin. Oncol. 14 1996 1848 1857
12. P Bassa E.E Kim T Inoue Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer J. Nucl. Med. 37 1996 931 938
13. K Scheidhauer A Scharl U Pietrzyk Qualitative [18F]FDG positron emission tomography in primary breast cancer clinical relevance and practicability Eur. J. Nucl. Med. 23 1996 618 623
14. H Palmedo H Bender F Grünwald Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours Eur. J. Nucl. Med. 24 1997 1138 1145
15. H Minn I Soini 18F)fluordeoxyglucose scintigraphy in diagnosis and follow up treatment in advanced breast cancer Eur. J. Nucl. Med. 15 1989 61 66
16. L.H Holle L Trampert S Lung-Kurt Investigation of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT J. Nucl. Med. 37 1996 615 622
17. W.H Martin D Delbeke J.A Patton M.P Sandler Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose Radiology 198 1996 225 231
18. S.K Mukherji W.E Drane A.A Mancuso J.T Parsons W.M Mendenhall S Stringer Occult primary tumors of the head and neck detection with 2-[F-18] fluoro-2-deoxy-D-glucose SPECT Radiology 199 1996 761 766
19. S Sugiyama Y Suzuki H Matsuzaki K Tomiyoshi K Endo Tumor diagnosis using 18F-FDG SPECT Nippon Igaku Hoshasen Gakkai Zasshi 56 1996 679 680
20. P.C Warnke A Berlis A Weyerbrock C.B Ostertag Effect of LINAC radiosurgery on regional cerebral blood flow, glucose metabolism and sodium-potassium ATPase in skull base meningiomas and metastases Acta Neurochir 68 1997 124 126 Suppl. (Wien)
21. D.F Worsley A Celler M.J Adam Pulmonary nodules differential diagnosis using 18F-fluorodeoxyglucose single-photon emission computed tomography Am. J. Roentgenol. 168 1997 771 774
22. W.M Mendelhall A.A Mancuso J.T Parsons S.P Stringer N.J Cassisi Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site Head Neck 20 1998 739 744
23. M Lonneux D Delval R Bausart Can dual-headed 18F-FDG SPET imaging reliably supersede PET in clinical oncology? A comparative study in lung and gastrointestinal tract cancer Nucl. Med. Commun. 19 1998 1047 1054
24. S.T Mastin W.E Drane E.M Harman J.J Fenton L Quesenberry FDG SPECT in patients with lung masses Chest 115 1999 1012 1017
25. R.E Coleman C.M Laymon T.G Turkington FDG imaging of lung nodules a phantom study comparing SPECT, camera-based PET, and dedicated PET Radiology 210 1999 823 828
26. Z Burak M Argon A Memis Evaluation of palpable breast masses with 99Tcm-MIBI a comparative study with mammography and ultrasonography Nucl. Med. Commun. 15 1994 604 612
27. C.H Kao S.J Wang T.J Liu The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses Eur. J. Nucl. Med. 21 1994 432 436
28. I Khalkhali I Mena E Jouanne Prone scintimammography in patients with suspicion of carcinoma of the breast J. Am. Coll. Surg. 178 1994 491 497
29. F Scopinaro O Schillaci M Scarpini Technetium-99m sestamibi an indicator of breast cancer invasiveness Eur. J. Nucl. Med. 21 1994 984 987
30. O Schillaci F Scopinaro R Danieli Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer Anticancer Res. 17 1997 1607 1610
31. H Palmedo H.J Biersack S Lastoria Scintimammography with technetium-99m methoxyisobutylisonitrile results of a prospective European multicentre trial Eur. J. Nucl. Med. 25 1998 375 385
32. B Higley F.W Smith H.G Gemmell Technetium-99m-1,2-bis[bis(2-ethoxyethyl)phosphino]ethan human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent J. Nucl. Med. 34 1993 30 38
33. Jain, D.; Wackers, J.T.H.; Mattera, J.; McMahon, M.; Sinusas, A.; Zaret, B.L. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J. Nucl. Med. 34:1254–9; 1993.
34. I Adalet O Demirkol M Müslümanoglu M Kocak Y Bozfakioglu S Cantez Tc-99m tetrofosmin scintigraphy in the evaluation of palpable breast masses preliminary results Eur. J. Nucl. Med. 22 1995 742
35. P.F Rambaldi L Mansi E Procaccini F Di Gregorio E Del Vecchio Breast cancer detection with Tc-99m tetrofosmin Clin. Nucl. Med. 20 1995 703 705
36. V Bongers A.J van Dongen R Pijnappel D.M.D.S Sie-Go B Rinkes P.P van Rijk Tc-99m-MyoviewTM scintigraphy in the dignosis of suspected breast cancer Eur. J. Nucl. Med. 23 1996 1095
37. L Mansi P.F Rambaldi E Procaccini Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases Eur. J. Nucl. Med. 23 1996 932 939
38. M.R Vieira J.H.B Weinholtz Technetium-99m-tetrofosmin scintigraphy in the diagnosis of breast cancer Eur. J. Surg. Oncol. 22 1996 331 334
39. H Yagcioglu S Ibis S Naldölken Differentiation of malignant and benign breast masses using Tc-99m-tetrofosmin comparison with mammography, ultrasonography and biopsy Eur. J. Nucl. Med. 23 1996 1094
40. J.F Batista M.E Solano J.P Oliva Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours Nucl. Med. Commun. 18 1997 338 340
41. H.M Fenlon N.C Phelan P O'Sullivan S Tierney T Gorey J.T Ennis Benign versus malignant breast disease comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography Radiology 205 1998 214 220
42. P Lind H.W Umschaden E Forsthuber Scintimammography using Tc-99m tetrofosmin Acta Med. Austriaca 24 1997 50 54
43. P Madariaga I Almoguera A Alonso Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions Anticancer Res. 17 1997 1619 1622
44. O Schillaci F Scopinaro R Danieli Scintimammography with technetium-99m tetrofosmin in suspected breast cancer Anticancer Res. 17 1997 1623 1626
45. K.H Bohuslavizki W Brenner C Bolling Scintimammography using tc-99m-tetrofosmin in preoperative work-up of breast cancer Eur. J. Nucl. Med. 23 1996 1094
46. V Ivančević S Marnitz K.-J Winzer Tc-99m-sestamibi and Tc-99m-tetrofosmin in planar scintimammography and SPECT intraindividual comparison J. Nucl. Med. 38 1997 233P
47. E Wandke S Marnitz U Dopichaj-Menge 99m-Tc-MIBI-Szintimammographie in Bauchlage mit spezieller Untersuchungsliege Nuklearmedizin 35 1996 TV5
48. U Dopichaj-Menge A Wolter V Ivančević D.L Munz Selection of the most suitable reconstruction filter for breast imaging with F-18 fluorodeoxyglucose SPECT Eur. J. Nucl. Med. 24 1997 1009
49. N Avril J Dose F Jänicke Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose J. Natl. Cancer Inst. 88 1996 1204 1209
50. F Crippa R Agresti E Seregni Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer J. Nucl. Med. 39 1998 4 8
51. D.J Macfarlane L Cotton R.J Ackermann Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) initial evaluation in oncology and comparison with FDG PET Radiology 194 1995 425 429
52. V Ivančević S Marnitz E Wandke I Reisinger D.L Munz Evaluation of the tumour/background ratio in planar scintimammography by a phantom study G.S Limouris S.K Shukla H.-J Biersack Radionuclides for mammary gland. Current status and future aspects 1997 Mediterra Publishers Athens, Greece 155–8
53. H Palmedo A Schomburg F Grünwald Technetium-99m-MIBI scintimammography for suspicious breast lesions J. Nucl. Med. 37 1996 626 630
54. J.R Buscombe J.B Cwikla D.S Thakrar A.J.W Hilson Uptake of Tc-99m MIBI related to tumour size and type Anticancer Res. 17 1997 1693 1694
55. V Ivančević Positron emission tomography (PET) in diagnosing breast cancer Zentralbl. Chir. 123 suppl 1998 53 56